Nabila El-Bassel1, Stacey A Shaw, Anindita Dasgupta, Steffanie A Strathdee. 1. aGlobal Health Research Center of Central Asia, Columbia University School of Social Work, New York, New York bDepartment of Medicine, University of California San Diego, La Jolla, California cJoint Doctoral Program in Public Health (Global Health), San Diego State University/University of California, San Diego, California, USA.
Abstract
PURPOSE OF REVIEW: We reviewed the studies published in 2012-2013 that focused on re-emerging and emerging injection and noninjection drug use trends driving HIV risk behaviors and transmission in some parts of the world. RECENT FINDINGS: Although HIV incidence has declined in many countries, HIV epidemics remain at troubling levels among key drug-using populations, including females who inject drugs (FWIDs), FWIDs who trade sex, sex partners of people who inject drugs, young people who inject drugs, and people who use noninjection drugs in a number of low-income and middle-income countries such as in Central Asia, Eastern Europe, Southeast Asia, and parts of Africa. SUMMARY: HIV epidemics occur within the contexts of global economic and political forces, including poverty, human rights violations, discrimination, drug policies, trafficking, and other multilevel risk environments. Trends of injection and noninjection drug use and risk environments driving HIV epidemics in Central Asia, Eastern Europe, Southeast Asia, and parts of Africa call for political will to improve HIV and substance use service delivery, access to combination HIV prevention, and harm reduction programs.
PURPOSE OF REVIEW: We reviewed the studies published in 2012-2013 that focused on re-emerging and emerging injection and noninjection drug use trends driving HIV risk behaviors and transmission in some parts of the world. RECENT FINDINGS: Although HIV incidence has declined in many countries, HIV epidemics remain at troubling levels among key drug-using populations, including females who inject drugs (FWIDs), FWIDs who trade sex, sex partners of people who inject drugs, young people who inject drugs, and people who use noninjection drugs in a number of low-income and middle-income countries such as in Central Asia, Eastern Europe, Southeast Asia, and parts of Africa. SUMMARY: HIV epidemics occur within the contexts of global economic and political forces, including poverty, human rights violations, discrimination, drug policies, trafficking, and other multilevel risk environments. Trends of injection and noninjection drug use and risk environments driving HIV epidemics in Central Asia, Eastern Europe, Southeast Asia, and parts of Africa call for political will to improve HIV and substance use service delivery, access to combination HIV prevention, and harm reduction programs.
Authors: George I Eluwa; Steffanie A Strathdee; Samson B Adebayo; Babatunde Ahonsi; Sylvia B Adebajo Journal: Drug Alcohol Depend Date: 2012-07-08 Impact factor: 4.492
Authors: Sarra L Hedden; Alicia Hulbert; Courtenay E Cavanaugh; Charles D Parry; Anne Gloria Moleko; William W Latimer Journal: J Subst Use Date: 2011-02
Authors: Jennifer L Syvertsen; Angela M Robertson; Lawrence A Palinkas; M Gudelia Rangel; Gustavo Martinez; Steffanie A Strathdee Journal: Cult Health Sex Date: 2013-03-11
Authors: Karla D Wagner; Eileen V Pitpitan; Claudia V Chavarin; Carlos Magis-Rodriguez; Thomas L Patterson Journal: Sex Transm Dis Date: 2013-08 Impact factor: 2.830
Authors: Steve Shoptaw; Brooke Montgomery; Chyvette T Williams; Nabila El-Bassel; Apinun Aramrattana; Lisa Metsch; David S Metzger; Irene Kuo; Francisco I Bastos; Steffanie A Strathdee Journal: J Acquir Immune Defic Syndr Date: 2013-07 Impact factor: 3.731
Authors: Keith J Horvath; Sara Lammert; Sara LeGrand; Kathryn E Muessig; José A Bauermeister Journal: Curr Opin HIV AIDS Date: 2017-09 Impact factor: 4.283
Authors: Jennifer L Glick; Aimee Huang; Rienna Russo; Belinda Jivapong; Vijayasundaram Ramasamy; Lori Rosman; Danielle Pelaez; Katherine H A Footer; Susan G Sherman Journal: Drug Alcohol Depend Date: 2020-08-02 Impact factor: 4.492